GL1X · GenesisL1 explorer

Research workbench

Hepatitis C virus polymerase NS5B with ro inhibitor for sar studies

Analyse Hepatitis C virus polymerase NS5B with ro inhibitor for sar studies in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6W4G
Type
protein
Length
1,104 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
NS5B
EC
2.7.7.48
UniProt
P26663
Ligands
SL4
Pockets
12 · best druggability 0.81

Structure

x-ray diffraction · 2 distinct chains · 49% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANS5B (EC 2.7.7.48)protein55750% helix, 15% strandP26663
BNS5B (EC 2.7.7.48)protein54748% helix, 15% strandP26663

Ligands and binding sites

  • SL4 · 5-[[(2~{S})-4-[1,1-bis(oxidanylidene)-1,2-benzothiazol-3-yl]-2-~{tert}-butyl-3-oxidanyl-5-oxidanylidene-2~{H}-pyrrol-1-yl]methyl]-2-fluoranyl-benzenecarbonitrile · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

12 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18240.810.8476SL4
210360.800.8283SL4
34490.730.8367empty
42490.680.8431empty
51000.480.8120empty

Interfaces

1 interface between chains.

  • A–B · 725 Ų buried · 5 hydrogen bonds · protein-protein

Compared structures

  • 6W4G · Hepatitis C virus polymerase NS5B with RO inhibitor for SAR studies · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.